广誉远：公司控股子公司山西广誉远国药有限公司收到国家药监局核准签发的半夏泻心汤颗粒《药品注册证书》

Group 1 - The core point of the article is that Guangyuyuan's subsidiary, Shanxi Guangyuyuan Traditional Chinese Medicine Co., Ltd., has received approval from the National Medical Products Administration for the registration of Banxia Xiexin Decoction granules, making it the first company in the country to obtain this drug registration certificate [1] - The drug is classified as a Category 3.1 traditional Chinese medicine compound preparation, managed according to ancient classic prescriptions [1] - The company is currently preparing for the drug's market launch in accordance with relevant regulations, although the sales situation may be influenced by policy and market factors, leading to uncertainties [1]